Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cephea Early Feasibility Study

NCT05061004 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT05061004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05061004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cephea Early Feasibility Study
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Recruiting
Start date
April 28, 2022
Completion date
March 1, 2031
Enrollment
90 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

mitral regurgitation